The Pathophysiology of Orthostatic Hypotension
NCT00748059 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2021-05-12
Summary
The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.
Conditions
- Autonomic Nervous System Diseases
- Orthostatic Hypotension
- Dopamine Beta-Hydroxylase Deficiency
- Orthostatic Intolerance
Interventions
- PROCEDURE
-
Standing or upright tilt
stand upright or tilt table test
- PROCEDURE
-
Microneurography
Recording from sympathetic nerve
- PROCEDURE
-
QSweat
quantitative sweat testing
- DEVICE
-
neck cuff stimulation
Blood pressure receptors in the neck arteries may be stimulated by applying suction through a collar around the neck.
- DRUG
-
phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine
IV Pharmacological Testing phenylephrine 12.5 - 400 ug, isoproterenol 0.1 - 0.4 ug or higher until desired effect, nitroprusside 0.1 - 1.6 ug/kg, propranolol 1.1 mg/min, edrophonium maximum of 10 mg, atropine .01 mg/kg, tyramine 250-4000 ug or higher until desired effect
- DRUG
-
clonidine,yohimbine,metoclopramide,alpha-methyldopa
Oral Pharmacological Testing clonidine 0.1-0.3 mg, yohimbine 5-10 mg, metoclopramide 10 mg, alpha-methyldopa 62.5 mg, placebo
- PROCEDURE
-
BodPod
Determination of body composition
- PROCEDURE
-
Eye exam
Examination of pressure in the eye and eyelid fatiguability. The following eyedrops might be used: 1. 0.5% proparacaine (Alcaine, Allergan, Inc) 2. Fluress (0.4% benoxinate hydrochloride, fluorescein sodium, Akorn, Inc) 3. 0.5%, 1% tropicamide (Mydriacyl, Alcon) 4. Over-the-counter preservative-free artificial tears 5. 0.25%, 2.5% and 10% phenylephrine (Bausch and Lomb) 6. 1% cyclopentolate hydrochloride (Alcon)
- PROCEDURE
-
Sleep study
Recording of sleep pattern overnight
- PROCEDURE
-
Pain response testing
Subjects will rate the quality and intensity of 2 pain tasks.
- PROCEDURE
-
Metabolic chamber
Determination of metabolic rate via 24hr stay in whole-room indirect calorimeter
- PROCEDURE
-
Brain function studies
Questionnaires and computer tasks, an EEG and an MRI may be used to assess brain function.
- PROCEDURE
-
Bicycle Exercise Test
Blood pressure and heart rate may be monitored while exercising on a stationary bicycle.
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Emily M Garland, PhD · Vanderbilt University
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-12-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
NCT02308124 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
NCT00426842 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Autonomic Disorders: A Training Protocol
NCT02154009 ·Status: TERMINATED
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043 ·Status: RECRUITING ·Phase: PHASE2
-
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
NCT02726711 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
NCT01518946 ·Status: COMPLETED ·Phase: PHASE4
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Exercise in OI
NCT00770484 ·Status: COMPLETED ·Phase: NA
-
Orthostatic Hypotension Among Veterans
NCT02123303 ·Status: COMPLETED
-
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
NCT03602014 ·Status: COMPLETED ·Phase: PHASE4
-
Nitric Oxide and the Autonomic Nervous System
NCT00178919 ·Status: COMPLETED ·Phase: NA
-
Autonomic Nervous System and Nitric Oxide Interactions
NCT01137253 ·Status: COMPLETED ·Phase: PHASE1
-
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Role of Endothelin in the Supine Hypertension of Autonomic Failure
NCT01119417 ·Status: WITHDRAWN ·Phase: PHASE1
-
POTS NET mRNA Functional Correlation With NET Activity
NCT03218761 ·Status: ACTIVE_NOT_RECRUITING
-
Using Mirabegron to Increase BP in Patients With POTS
NCT06133075 ·Status: COMPLETED ·Phase: PHASE2
-
Autonomic Determinants of POTS - Pilot1
NCT04050410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System
NCT03109795 ·Status: TERMINATED ·Phase: PHASE4
-
Nebivolol in the Supine Hypertension of Autonomic Failure
NCT01044693 ·Status: COMPLETED ·Phase: NA
-
Hypnosis in Autonomic Function
NCT00061009 ·Status: COMPLETED
-
A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study.
NCT06039410 ·Status: RECRUITING ·Phase: NA
-
Non-Pharmacologic Therapy for Neurocardiogenic Syncope
NCT00096902 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
NCT01297335 ·Status: COMPLETED ·Phase: PHASE2